Clinical Trial Update: Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial in Malawi is assessing the efficacy of Typhoid Conjugate Vaccine (Vi-TCV) in children aged 9 months to 12 years; the study status is ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Typhoid Fever

Drugs mentioned

• Typhoid Conjugate Vaccine (Vi-TCV) (typhoid conjugate vaccine (Vi-TCV))

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Typhoid | Phase 3 | Status: ACTIVE_NOT_RECRUITING